Article
Sulfonylurea Therapy Benefits Neurological and Psychomotor Functions in Patients With Neonatal Diabetes Owing to Potassium Channel Mutations.
Diabetes care - 1 Nov 2015
Beltrand Jacques, Elie Caroline, Busiah Kanetee, Fournier Emmanuel, Boddaert Nathalie, Bahi-Buisson Nadia, Vera Miriam, Bui-Quoc Emmanuel, Ingster-Moati Isabelle, Berdugo Marianne, Simon Albane, Gozalo Claire, Djerada Zoubir, Flechtner Isabelle, Treluyer Jean-Marc, Scharfmann Raphael, Cavé Helene, Vaivre-Douret Laurence, Polak Michel
Abstract excerpt
OBJECTIVE: Neonatal diabetes secondary to mutations in potassium-channel subunits is a rare disease but constitutes a paradigm for personalized genetics-based medicine, as replacing the historical treatment with insulin injections with oral sulfonylurea (SU) therapy has been proven beneficial. SU receptors are widely expressed in the brain, and we therefore evaluated potential effects of SU on neurodevelopmental...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
